Skip to content
10-Q

Quarterly Report

Bohai Pharmaceuticals Group, Inc.

0001144204-13-061724

← back to feed
Filed
Nov 14, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · Nov 14, 2013 17.86M sh
Short Term Debt Q1 2014 · Sep 30, 2013 $4.88M
Short Term Debt Q1 2014 · Sep 30, 2013 ¥30M
Short Term Debt Q1 2014 · Jun 30, 2013 $0
Stockholders Equity Q1 2014 · Sep 30, 2013 $117.1M
Stockholders Equity Q1 2014 · Jun 30, 2013 $108.39M
Current Liabilities Q1 2014 · Sep 30, 2013 $51.51M
Current Liabilities Q1 2014 · Jun 30, 2013 $44.19M
Total Liabilities Q1 2014 · Sep 30, 2013 $59.6M
Total Liabilities Q1 2014 · Jun 30, 2013 $57.23M
Current Assets Q1 2014 · Sep 30, 2013 $73.5M
Current Assets Q1 2014 · Jun 30, 2013 $61.52M
Total Assets Q1 2014 · Sep 30, 2013 $176.71M
Total Assets Q1 2014 · Jun 30, 2013 $165.62M
Shares Diluted Q1 2014 · Sep 30, 2012 22.56M sh
Capex Q1 2014 · Sep 30, 2012 $11.34K
Operating Cash Flow Q1 2014 · Sep 30, 2012 $1.58M
Cash And Equivalents Q1 2014 · Sep 30, 2012 $19.38M
Cash And Equivalents Q1 2014 · Jun 30, 2012 $18.39M
Eps Diluted restated Q1 2014 · Sep 30, 2012 $0.30
Eps Basic Q1 2014 · Sep 30, 2012 $0.36
Sga Expense Q1 2014 · Sep 30, 2012 $17.21M
Rd Expense restated Q1 2014 · Sep 30, 2012 $2K
Net Income Q1 2014 · Sep 30, 2012 $6.4M
Operating Income Q1 2014 · Sep 30, 2012 $8.59M
Gross Profit restated Q1 2014 · Sep 30, 2012 $26.45M